Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestrant and Zoladex in Premenopausal Metastatic Breast Cancer
NCT03591549Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Aug 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of fulvestrant in breast cancer, sponsored by Assiut University. Status: unknown.
02
Drugs
fulvestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03591549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03591549.